Search results
23 lis 2022 · IN JANUARY 2022, Bjornevik and colleagues published the results of a 20-year prospective seroepidemiologic study on the relationship between Epstein-Barr virus (EBV) and multiple sclerosis (MS) in which investigators observed an enormous increase in the risk of MS after EBV infection.
24 sty 2022 · Six of the nine MS patients had antibodies that bound to the EBV protein EBNA1, and eight of nine had antibodies to some fragment of EBNA1. The researchers focused on one antibody that binds EBNA1 in a region known to elicit high reactivity in MS patients.
12 lip 2022 · Recent research has shown a link between the Epstein-Barr virus (EBV) and multiple sclerosis (MS). Whether you have been diagnosed with MS or are curious about what this new research means for the future of MS care, here are answers to a few common questions about EBV and MS.
March 27, 2024—People living with multiple sclerosis (MS) had a stronger immune response to Epstein-Barr virus (EBV) than those without MS—but their response did not follow a specific pattern that could help highlight the disease’s origins, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.
7 lut 2023 · Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven immunopathological mechanism
16 lip 2022 · Several anti-herpes virus compounds, including famciclovir and abacavir, have been evaluated for the treatment of MS, but they have shown poor therapeutic efficacy for MS.
9 lut 2023 · Epidemiological studies have provided compelling evidence that multiple sclerosis (MS) is a rare complication of infection with the Epstein–Barr virus (EBV), a herpesvirus that infects...
